$ News

Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform

SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates

SurModics: Fiscal Q3 Earnings Snapshot

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8

Evolus, Inc. (EOLS) Reports Q2 Loss, Lags Revenue Estimates

Surmodics still recovering after June cyberattack

QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?

Are Options Traders Betting on a Big Move in Surmodics Stock?

SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say

SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates

SurModics: Fiscal Q2 Earnings Snapshot

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

Illinois, Minnesota join FTC challenge against $627M Surmodics buyout

Surmodics launches Pounce XL thrombectomy system